Silexion Therapeutics Ltd. (SLXN) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $280,482, listed on NASDAQ, employing roughly 11 people, carrying a beta of -0.29 to the broader market. Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. Led by Ilan Hadar, public since 2024-08-16.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for SLXN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →